| This article has been cited by |
| 1 | The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer | |
| Daniel C. Parker,Michael S. Cookson |
| Investigative and Clinical Urology.2020;61(Suppl 1)S3 |
| [DOI] |
|
| 2 | Population-Based Study of Docetaxel or Abiraterone Effectiveness and Predictive Markers of Progression Free Survival in Metastatic Castration-Sensitive Prostate Cancer | |
| Juan Briones,Maira Khan,Amanjot K. Sidhu,Liying Zhang,Martin Smoragiewicz,Urban Emmenegger |
| Frontiers in Oncology.2021;11(Suppl 1)S3 |
| [DOI] |
|
| 3 | Duplicated network meta-analysis in advanced prostate cancer: a case study and recommendations for change | |
| David J. Fisher,Sarah Burdett,Claire Vale,Ian R. White,Jayne F. Tierney |
| Systematic Reviews.2022;11(1)S3 |
| [DOI] |
|
| 4 | Notwendigkeit neuer Begrifflichkeiten | |
| Holger H.H. Erb,Christian Thomas |
| Uro-News.2020;24(11)10 |
| [DOI] |
|
